We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

β-globin Restored Autologous HSC in β-thalassemia Major Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04205435
Recruitment Status : Terminated (Sponsor decision)
First Posted : December 19, 2019
Last Update Posted : October 13, 2022
PLA 923 Hospital
Information provided by (Responsible Party):
Bioray Laboratories

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 1, 2022
Actual Study Completion Date : July 25, 2022